HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$5.44
Day range
$5.25 - $5.64
Year range
$3.51 - $17.85
Market cap
45.96M USD
Avg Volume
110.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 30.02M | -9.39% |
Operating expense | 61.97M | 109.72% |
Net income | -23.46M | 37.20% |
Net profit margin | -78.17 | 30.69% |
Earnings per share | -2.77 | 42.29% |
EBITDA | -33.18M | 1.47% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 69.94M | -52.93% |
Total assets | 127.71M | -37.54% |
Total liabilities | 333.60M | -10.66% |
Total equity | -205.88M | — |
Shares outstanding | 8.64M | — |
Price to book | -0.23 | — |
Return on assets | -56.92% | — |
Return on capital | -121.97% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.46M | 37.20% |
Cash from operations | -38.98M | 10.84% |
Cash from investing | 15.29M | -30.32% |
Cash from financing | — | — |
Net change in cash | -23.69M | -8.67% |
Free cash flow | -29.94M | 4.27% |
About
Founded
2008
Headquarters
Website
Employees
279
